Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:37 PM
Ignite Modification Date:
2025-12-24 @ 5:37 PM
NCT ID:
NCT00000368
Eligibility Criteria:
Inclusion Criteria:
\- primary diagnosis of Panic disorder with or without Agoraphobia (all levels of agoraphobia are included).
Exclusion Criteria:
* current substance abuse or dependence,
* current active suicidal potential;
* any history of psychosis, bipolar disorder (I or II) or cyclothymia;
* pending application or existing medical disability claim;
* significant cognitive impairment,
* current uncontrolled general medical illness requiring intervention,
* psychotherapy directed at anxiety or panic which will not be discontinued by the first treatment visit, and daily use of 2mg of Xanax or equivalent.
Exclusion criteria for paroxetine study:
* hypersensitivity to Selective Serotonin Reuptake Inhibitors (SSRI),
* pregnancy, lactation, or planned pregnancy during the course of the study,
* contemporaneous medication that may interfere or interact with paroxetine,
* prior treatment with therapeutic doses of paroxetine (40mg/d for 1 mo),
* concurrent treatment with antidepressants.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00000368
Study Brief:
Protocol Section:
NCT00000368